Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
Top Cited Papers
- 1 July 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 12 (7), 637-649
- https://doi.org/10.1016/s1474-4422(13)70088-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Striatal Volume Contributes to the Prediction of Onset of Huntington Disease in Incident CasesBiological Psychiatry, 2012
- Age, CAG repeat length, and clinical progression in Huntington's diseaseMovement Disorders, 2011
- A tale of two factors: What determines the rate of progression in Huntington's disease? A longitudinal MRI studyMovement Disorders, 2011
- Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 yearMovement Disorders, 2011
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisThe Lancet Neurology, 2010
- Longitudinal change in regional brain volumes in prodromal Huntington diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Striatal and white matter predictors of estimated diagnosis for Huntington diseaseBrain Research Bulletin, 2010
- Self-paced timing detects and tracks change in prodromal Huntington disease.Neuropsychology, 2010
- The control of the false discovery rate in multiple testing under dependencyThe Annals of Statistics, 2001